Company Filing History:
2 out of 330 
2 out of 74 
1 out of 2 Years Active: 2009-2011
Title: Douglas Ringler: Innovator in Primate Tolerance Research
Introduction
Douglas Ringler is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of immunology, particularly in the area of inducing tolerance in primates. With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical applications.
Latest Patents
Ringler's latest patents focus on compositions and methods for tolerizing a primate to an antigen. The first patent involves inducing tolerance in a primate using a compound or a combination of at least two compounds that exhibit specific characteristics when tested in vitro. The preferred compound in this patent is the TRX1 antibody, which is utilized according to a specified dosing regimen. The second patent also addresses the induction of tolerance in a primate, again emphasizing the use of the TRX1 antibody in combination with other compounds, following a defined dosing regimen.
Career Highlights
Throughout his career, Douglas Ringler has worked with notable organizations, including Isis Innovation Limited and Cambridge University Technical Services Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of immunology.
Collaborations
Ringler has collaborated with esteemed colleagues such as Mark Raymond Frewin and Herman Waldmann. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Douglas Ringler's work in the field of primate tolerance research showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing new therapeutic strategies that could benefit future medical treatments.